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INTRODUCTION
Ovarian hyperstimulation syndrome (OHSS) is a life-
threatening iatrogenic complication of in vitro fertilization
(IVF).
1 One of the characteristic features of OHSS is
increased vascular permeability due to the overproduction
of vasoactive mediators from hyperstimulated and enlarged
ovaries. Such altered permeability leads to fluid shifts from
intravascular to interstitial or third-space compartments.
2-4
Clinical manifestations, therefore, include hemoconcentra-
tion, hypovolemia, decreased renal perfusion, hypotension,
electrolyte imbalance, and in severe forms (0.5%–5% of
cases), tense ascites.
5,6 In addition, lower-than-normal levels
of plasma immunoglobulin have been detected in patients
with severe OHSS,
7 which may predispose patients to
serious infections.
8 In this report, we describe a woman with
OHSS without previous liver disease who developed a
previously unreported infectious complication: spontaneous
bacterial peritonitis (SBP).
CASE DESCRIPTION
A 36-year-old woman was admitted to Hospital das
Clı ´nicas, University of Sa ˜o Paulo, Brazil during her
pregnancy five weeks after IVF was performed at another
health service. She was previously healthy but had
attempted IVF three times without success. The previous
IVF procedure had been complicated with mild OHSS that
did not require hospitalization or treatment. The protocols
for ovarian stimulation and ovulation induction were
unknown. The patient had also noticed abdominal enlarge-
ment at the time of oocyte retrieval (25 oocytes collected).
Five days later, two embryos were transferred, and human
albumin was administered intravenously.
Three weeks after embryo transfer, she was admitted to
our service due to abdominal discomfort, hyperemesis, low
urine output, and weight gain (7 kg in the previous seven
days). The patient’s core temperature and blood pressure
were normal. Her abdomen was distended, and ascites was
detectable during physical examination. Although her
breathing and oxygen saturation in room air were normal,
small bilateral pleural effusions were observed on the
thoracic radiographs.
Transabdominal ultrasonographic examination at admis-
sion revealed a viable intrauterine twin pregnancy
with bilateral multiloculated cystic ovaries (right ovary
5.864.464.8 cm, estimated volume 64 cm
3; left ovary
5.964.565.3 cm, estimated volume 86 cm
3) and ascites.
Laboratory values were as follows: hemoglobin, 15 g/dL;
hematocrit, 42.7%; leukocyte count, 18,540/mm
3; platelet
count, 450,000/mL; serum sodium, 133 mmol/L; potassium,
4.7 mmol/L; creatinine, 0.6 mg/dL; and albumin, 3.5 g/dL.
The levels of hepatic transaminases were slightly elevated
(AST 45 IU/L, ALT 27 IU/L), but the bilirubin levels were
normal. The results of a hormonal assay for thyroid function
were normal. The serum E2 level was 6,204 pg/mL, and the
human chorionic gonadotropin level was 14,765 mIU/mL.
Serology results for viral hepatitis were negative.
OHSS was suspected, and supportive care in the intensive
care unit (ICU) was initiated. Intravenous crystalloid
hydration and 20% albumin (150 mL/day) was started.
Heparin (5,000 IU three times a day) was administered for
thromboembolic prophylaxis. The patient responded well
and maintained adequate urine output. The hemoconcen-
tration resolved, and the patient was discharged to an
obstetric ward.
After one week, the patient developed fever, shivering,
and renal failure (creatinine 1.68 mg/dL). C-reactive protein
increased from 42.7 to 116 mg/L. Because of the respiratory
compromise, transvaginal paracentesis was performed
during which 4 L of ascites was aspirated. Fluid analysis
revealed 520 cells/mm
3 with 400 polymorphonuclear
(PMN) cells/mm
3 and a total protein concentration of
5.0 g/dL. Escherichia coli was recovered from the ascitic fluid
culture. Ceftriaxone was initiated, guided by a culture
antibiogram. Human albumin was administered at 1.5 g/kg
on the first day and at 1.0 g/kg on the third day of antibiotic
treatment. The patient’s general condition and renal func-
tion improved. No other source of infection was discovered.
After 48 h of treatment, another transvaginal paracentesis
was necessary to alleviate discomfort from tense ascites.
Fluid analysis demonstrated improvement of the cell count
(from 520/mm
3 to 280/mm
3). Ceftriaxone was discontinued
after eight days of treatment.
The patient remained in the hospital for another month
because of two further episodes of bacteremia documented
by blood cultures (one episode with Escherichia coli ESBL
and the other with Acinetobacter baumannii). Both episodes
were successfully treated with antibiotics (E. coli treated
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2173with piperacillin/tazobactam and A. baumannii with mer-
openem) and by transvaginal paracentesis (5 L of ascites
aspirated) with albumin infusion for the alleviation of
abdominal hypertension and discomfort. The patient was
discharged from the hospital after a total of two months of
hospitalization.
At 31 weeks of gestation, the patient was readmitted for
assessment of fetal vitality. At 34 weeks of gestation,
premature rupture of membranes occurred. Caesarean
section was performed without complications. The mother
and both babies were discharged in good condition two
days after the delivery.
DISCUSSION
Ovarian hyperstimulation syndrome is an iatrogenic
complication of the ovarian stimulation commonly used
for IVF. The condition is potentially life-threatening; there-
fore, it represents one of the most serious complications of
assisted reproduction treatments.
9 In this case report, we
describe SBP as a new infectious complication of OHSS.
Summary of the case report and SBP as a novel
infection in OHSS
We presented a patient with serious illness due to OHSS.
Some laboratory findings for our patient were characteristic
of severe OHSS, including leukocytosis (white blood cell
count .15,000), electrolyte imbalances (hyponatremia:
sodium ,135 mEq/L), and elevated liver enzymes.
1 The
evolution of this condition was complicated by the
occurrence of SBP due to E. coli, which was successfully
treated with antibiotics and intravenous human albumin
administration.
SBP is characterized by the spontaneous infection of
ascitic fluid in the absence of an intraabdominal source of
infection.
12 The occurrence of peritonitis associated with
OHSS was the subject of a previous case report, but in that
case, the infection was due to perforated appendicitis.
13 No
previous report of an association between SBP and OHSS
was found. Therefore, the occurrence of this infectious
complication during OHSS appears to be novel.
The occurrence of SBP in OHSS
The most important aspect of our case report is the
evidence of SBP as a cause of sepsis during OHSS. The
presence of .250 PMN cells/mm
3 in the ascitic fluid is
diagnostic of this condition and mandates immediate
treatment.
12 Ascitic fluid cultures are negative in 30-50%
of cases and, when positive, usually grow gram-negative
enteric bacteria (typically Escherichia coli and Klebsiella
pneumoniae). When $250 PMN cells/mm
3 are present in
ascites, patients with positive or negative ascitic fluid
cultures share common clinical, prognostic, and therapeutic
characteristics. A delay in antibiotic treatment could result
in a significant and potentially fatal deterioration in clinical
status.
14 Such infections are typically associated with
advanced cirrhosis, rather than non-cirrhotic ascites.
14 This
finding probably reflects the constellation of derangements
that occur with cirrhosis, such as increased intestinal
permeability with bacterial translocation into the blood-
stream, alteration in the systemic immune system, and
impaired ascitic fluid defense mechanisms.
14 Specifically, a
low protein concentration in the ascitic fluid predisposes
patients to SBP.
15-17 The ascitic fluid in OHSS patients
typically has a high protein concentration, with elevated
levels of albumin and IgG.
7,18 Therefore, elevated opsonic
activity is expected, and SBP is likely to be a rare event.
Nevertheless, hypogammaglobulinemia occurs in cases of
severe OHSS and might predispose patients to severe
infections.
7,8 Our patient had 400 PMN cells/mm
3 and a
positive culture for Enterobacteriaceae, which is diagnostic of
SBP, and two additional severe infections, suggesting a
predisposition for infections.
Albumin administration has been suggested to be an
effective plasma expander in OHSS, and it has also been
demonstrated to be beneficial in the treatment of cirrhotic
patients with SBP.
1,11,19 Sort et al.
19 established that in
addition to antibiotics, albumin reduces mortality and renal
impairment if given early at a dose of 1.5 g/kg of body
weight at the time of diagnosis followed by 1 g/kg on day 3.
The mechanisms of action might be related to the preven-
tion of circulatory dysfunction and to the subsequent
activation of vasoconstrictor systems. Because the pathogen-
esis of OHSS and cirrhosis share some features (low arterial
pressure, vasodilation, activation of vasoconstrictor sys-
tems),
18,20 albumin administration for the prevention of
hemodynamic derangement in patients with OHSS may be
beneficial. Clinical trials specifically designed to evaluate
this aspect are needed. In our case, we decided to treat the
patient as suggested for cirrhotic patients despite the lack of
evidence for good recovery when applied to OHSS.
Risk factors and the prevention of OHSS
Recognition of the risk factors for OHSS is a crucial step in
the identification of patients with a high-risk profile who
would demand careful follow-up after ovulation induction
and might benefit from prevention strategies. The described
risk factors for OHSS include young age, low body weight,
polycystic ovary syndrome, and previous episodes of
OHSS.
1,6-8 The large number of retrieved oocytes in this
case is also of concern because it may be associated with
OHSS.
11 Our patient also reported a previous episode of
OHSS, and importantly, described symptoms at the time of
embryo transfer. The transfer of two embryos into a patient
with this condition, as in this case, is perhaps inadvisable for
a high-risk patient already exhibiting OHSS symptoms. The
transfer of a single embryo would eliminate the possibility
of multiple pregnancies and, perhaps, reduce the incidence
of OHSS.
5
Several strategies have been reported to prevent OHSS,
including albumin administration, coasting, dopamine
agonists, in vitro maturation of oocytes, reduced human
chorionic gonadotropin (hCG) dosage, non-steroidal anti-
inflammatory administration, GnRH antagonist protocol,
and using a GnRH agonist instead of hCG to induce oocyte
maturation.
4,5,9 The last two strategies have been reported to
achieve good results in preventing OHSS.
4 A recent update
of a Cochrane review comparing GnRH antagonists with
agonists demonstrated that the OHSS rate in women
receiving antagonists is significantly lower than in those
treated with the agonist protocols.
21 Although albumin was
administered and has previously been used in high-risk
women for OHSS prevention,
4,5 most recent evidence does
not support this practice.
22
In conclusion, we describe SBP as a novel life-threatening
infectious complication of OHSS. In cases of sepsis with
unknown causes, prompt paracentesis to determine the cell
count may reveal SBP. The timely administration of
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2174antibiotics is indicated if the diagnosis of SBP is made.
Minimizing the risk of OHSS is a key issue, and the
importance of the prevention of OHSS cannot be over-
emphasized.
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